Literature DB >> 8218426

Post-psychotic depression in schizophrenia.

M Chintalapudi1, P Kulhara, A Avasthi.   

Abstract

Post-psychotic depression (PPD) is defined as the development of depression during the phase of remission of schizophrenia. Two groups of DSM-III-R schizophrenics, one with PPD and the other without PPD (30 subjects in each group) were compared. Significantly more patients in PPD group belonged to nuclear families, had longer duration of psychotic phase of the illness, were hospitalised more frequently and had more sadness and anxiety-somatisation during florid illness phase. The PPD group also had more past history of depression. Although PPD patients had better premorbid personal-social adjustment in comparison with non-PPD group, they perceived themselves to be lacking in social support and had experienced more stressful life events. For patients in the PPD group, stepwise multiple regression analysis revealed age of onset, sadness during florid psychotic state, premorbid adjustment, social support and life events as significant determinants of severity of depression in the post-psychotic phase.

Entities:  

Mesh:

Year:  1993        PMID: 8218426     DOI: 10.1007/bf02191572

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  34 in total

1.  An abbreviated form of the Phillips Rating Scale of Premorbid Adjustment in Schizophrenia.

Authors:  J G Harris
Journal:  J Abnorm Psychol       Date:  1975-04

2.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

3.  Postpsychotic collapse in schizophrenia.

Authors:  Y Mino; S Ushijima
Journal:  Acta Psychiatr Scand       Date:  1989-10       Impact factor: 6.392

4.  "Akinetic depression" in schizophrenia.

Authors:  T Van Putten; R P May
Journal:  Arch Gen Psychiatry       Date:  1978-09

5.  Postpsychotic depression in schizophrenics.

Authors:  M J Stern; J A Pillsbury; S M Sonnenberg
Journal:  Compr Psychiatry       Date:  1972 Nov-Dec       Impact factor: 3.735

6.  Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride.

Authors:  G E Hogarty; N R Schooler; R Ulrich; F Mussare; P Ferro; E Herron
Journal:  Arch Gen Psychiatry       Date:  1979-11

7.  Depression in chronic schizophrenia.

Authors:  A Roy; R Thompson; S Kennedy
Journal:  Br J Psychiatry       Date:  1983-05       Impact factor: 9.319

8.  A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.

Authors:  I Falloon; D C Watt; M Shepherd
Journal:  Psychol Med       Date:  1978-02       Impact factor: 7.723

9.  Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors:  S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal:  Br Med J       Date:  1973-03-17

10.  The time structure of depressive mood in schizophrenic patients.

Authors:  F Strian; R Heger; C Klicpera
Journal:  Acta Psychiatr Scand       Date:  1982-01       Impact factor: 6.392

View more
  3 in total

1.  Progressive symptom-associated prefrontal volume loss occurs in first-episode schizophrenia but not in affective psychosis.

Authors:  Toshiyuki Ohtani; Elisabetta Del Re; James J Levitt; Margaret Niznikiewicz; Jun Konishi; Takeshi Asami; Toshiro Kawashima; Tomohide Roppongi; Paul G Nestor; Martha E Shenton; Dean F Salisbury; Robert W McCarley
Journal:  Brain Struct Funct       Date:  2018-04-18       Impact factor: 3.270

Review 2.  Postpsychotic depression in schizophrenia patients.

Authors:  Christian G Kohler; Elise A Lallart
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

3.  Schizophrenia research: Indian scene in last decade.

Authors:  Ajit Avasthi; Gagandeep Singh
Journal:  Indian J Psychiatry       Date:  2004-04       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.